Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
01/25/2012
Trade Name:
TISSEEL
Generic or Proper Name (*):
Fibrin Sealant*
Indications Studied:
Hemostasis: An adjunct to hemostasis in patients undergoing surgery when control of bleeding by conventional surgical techniques (such as suture, ligature, and cautery) is ineffective or impractical. TISSEEL is effective in heparinized patients. Sealing: An adjunct to standard surgical techniques (such as suture and ligature) to prevent leakage from colonic anastomoses following the reversal of temporary colostomies
Therapeutic Category:
Wound healing
Ages Studied:
6 months - 16 years
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Randomized/Open label, Controlled
No Patients:
333
No Centers:
11
No Countries:
1
BPCA(B), PREA(P):
P
Asian:
0
Black:
0
Other:
0
White:
0
Unknown:
0
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
Countries:
0
-
-